Hi, what are you looking for?
Jewish Business News
Search results for " Teva Pharmaceutical"
Business
Dutch Stichting Foundation notified Mylan that it has exercised its call option to acquire 488, 388, 431 Mylan preferred shares pursuant to the...
Business
The groups told the US FTC: Increased consolidation has already led to higher prices and to generic drug shortages.
Business
Teva is the first applicant to receive approval and will have market exclusivity for generic Axert until November.
Business
As Israel’s biggest company Teva strives to get even bigger by swallowing up rival Mylan for more than $40 billion, further down the food...
Business
Last week Teva CEO, Erez Vigodman said, “If the Mylan Pharmaceuticals shareholders support the acquisition of Perrigo, Teva will abandon its bid for Mylan.”
Business
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) CEO Erez Vigodman said today, “If the Mylan Pharmaceuticals shareholders support the acquisition of...
Business
Erez Vigodman: Size isn't everything; it's important to be better.
Business
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has completed first step to buy its rival Mylan N.V. (Nasdaq: MYL). The Israeli giant announced...
Business
Teva says it will seek ‘further appellate review’
Business
Teva is now close to the 4.6% stake in Mylan that will give it standing in the Netherlands courts.